@windhamvp

Windham Portfolio Company Spotlight: An Interview with Welldoc CEO, Ryan Sysko

Ryan Sysko is the Founder and Chief Executive Office of WellDoc, a healthcare IT company focused on building a best-in-class mobile health platform for chronic disease management. The Company’s initial … Continued

Windham Fund Invests In Rapidly Growing Electrophysiology Market with Vytronus

We are excited to report that, in late October, Windham invested in VytronUS’s $31.6M Series B financing, alongside New Enterprise Associates (NEA), Apple Tree Partners, BioStar Ventures and Abbott Ventures. … Continued

GlySens Incorporated Awarded $2 Million Grant from the National Institutes of HealthFunding provided to support human clinical evaluation of next generation diabetes monitoring system

GlySens Incorporated Awarded $2 Million Grant from the National Institutes of HealthFunding provided to support human clinical evaluation of next generation diabetes monitoring system SAN DIEGO, Nov. 24, 2014 /PRNewswire/ … Continued

Novocure Announces the EF-14 Phase III Clinical Trial of Tumor Treating Fields in Patients with Newly Diagnosed Glioblastoma has been Terminated at the Interim Analysis due to Early Success

ST. HELIER, Jersey, Nov. 15, 2014 /PRNewswire/ — Novocure™, a commercial stage oncology company, announced today that Tumor Treating Fields (TTFields) delivered by the NovoTTF™-100A System in combination with standard-of-care … Continued